Felix Baker, Director, 10% Owner at Kymera Therapeutics, Inc. (KYMR), bought 2,005,813 shares at $86.00 ($172.5M) on 2025-12-11, disclosed to the SEC on 2025-12-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.00 | 167,192 | $14.4M | 8.3% |
| 2 | $86.00 | 1,838,621 | $158.1M | 91.7% |
| Total | $86.00 avg | 2,005,813 | $172.5M | 100% |
| Filing → |
| KALA | BUY | 2024-12-31 | $4.0M | — | Filing → |
| MDGL | BUY | 2023-11-15 | $31.4M | — | Filing → |
| KOD | BUY | 2022-05-27 | $4.3M | — | Filing → |